HSDT - Helius Medical Technologies Inc Stock Price, Fair Value and News

$0.46-0.02 (-4.17%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

HSDT Price Action

Last 7 days

-10.5%

Last 30 days

-7.3%

Last 90 days

-27.1%

Trailing 12 Months

-92.4%

HSDT RSI Chart

HSDT Valuation

Market Cap

1.7M

Price/Earnings (Trailing)

-0.19

Price/Sales (Trailing)

3.42

EV/EBITDA

0.2

Price/Free Cashflow

-0.16

HSDT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

HSDT Fundamentals

HSDT Revenue

Revenue (TTM)

502.0K

Rev. Growth (Yr)

-64.34%

Rev. Growth (Qtr)

-71.98%

HSDT Earnings

Earnings (TTM)

-8.9M

Earnings Growth (Yr)

-0.63%

Earnings Growth (Qtr)

-128.66%

HSDT Profitability

EBT Margin

-1764.74%

Return on Equity

-233.19%

Return on Assets

-158.62%

Free Cashflow Yield

-624.21%

HSDT Investor Care

Shares Dilution (1Y)

426.39%

Diluted EPS (TTM)

-6.05

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	668.0K	594.0K	502.0K	0
2023	708.0K	845.0K	792.0K	644.0K
2022	628.0K	676.0K	763.0K	787.0K
2021	538.5K	476.5K	454.5K	522.0K
2020	1.0M	641.5K	622.5K	661.5K
2019	732.6K	987.3K	1.2M	1.5M
2018	0	353.1K	415.6K	478.0K
2016	103.3K	165.8K	228.2K	290.7K
2015	0	0	0	0
2014	807.4K	0	0	0
2013	4.3M	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Helius Medical Technologies Inc

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

CEO	Mr. Dane Carl Andreeff
WEBSITE	https://heliusmedical.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	26

Helius Medical Technologies Inc Frequently Asked Questions

What is the ticker symbol for Helius Medical Technologies Inc? What does HSDT stand for in stocks?

HSDT is the stock ticker symbol of Helius Medical Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Helius Medical Technologies Inc (HSDT)?

As of Tue Nov 19 2024, market cap of Helius Medical Technologies Inc is 1.71 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HSDT stock?

You can check HSDT's fair value in chart for subscribers.

Is Helius Medical Technologies Inc a good stock to buy?

The fair value guage provides a quick view whether HSDT is over valued or under valued. Whether Helius Medical Technologies Inc is cheap or expensive depends on the assumptions which impact Helius Medical Technologies Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HSDT.

What is Helius Medical Technologies Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Nov 19 2024, HSDT's PE ratio (Price to Earnings) is -0.19 and Price to Sales (PS) ratio is 3.42. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HSDT PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Helius Medical Technologies Inc's stock?

In the past 10 years, Helius Medical Technologies Inc has provided -0.658 (multiply by 100 for percentage) rate of return.